GLI1 and melanoma: Human melanoma cell lines LOX IMVI and UACC 257 harboring BRAFV600E mutation were treated with PLX-4032 and subsequently subjected to WB analysis for the expression of GLI1 and phospho-ERK 1/2 (as a marker for MAPK inhibition).